• L'utilisation de stimulants illicites (en particulier la méthamphétamine) est en hausse au
Canada et est associée à des taux de morbidité et de mortalité substantiels.• De plus en …

• Accumulating evidence supports treatment of stimulant use disorder with prescribed
psychostimulants, but no pharmacologic treatments for stimulant use disorder are currently …

In a recent article published in CMAJ, Drs. Palis and McDonald 1 present evidence from a
systematic review to support a claim that prescription psychostimulants are not associated …

Points essentiels La méthamphétamine est actuellement la substance illicite la plus
consommée, après le cannabis, en Amérique du Nord, dans l'Est et le Sud-est de l'Asie, en …

Les universités et les collèges doivent en faire plus pour protéger nos jeunes adultes des
dangers liés à l'utilisation de stimulants illicites et pour les renseigner sur cette question …

In their CMAJ article, Drs. Palis and MacDonald1 advocate for expanded util ization of
prescribed psychostimulants as a treatment option within the care continuum for people with …

We thank Morin et al for their response. We agree that implementation studies are needed to
continue to build real world protocols for the provision of prescription psychostimulants (PPs) …

Method: A time series analysis of data from the 1994 to 2009 National Ambulatory Medical
Care Surveys (no. of visits= 372,702) was performed, focusing on adult (aged≥ 18 years) …

Härtel-Petri et al. mark out familiar territory in highlighting the weak evidence base for
medications to treat methamphetamine-dependent people. Their findings reiterate the …

Objectives: Few people who use stimulants seek clinical treatment. This study sought to
describe a cohort of stimulant users who attended a stimulant-specific treatment service …